أعرض في EDS

754P Ibrutinib (Ibr) in combination with paclitaxel (Pac) has activity in patients (Pts) with advanced urothelial carcinoma (aUC): Final analysis of a phase Ib/II study

التفاصيل البيبلوغرافية
العنوان: 754P Ibrutinib (Ibr) in combination with paclitaxel (Pac) has activity in patients (Pts) with advanced urothelial carcinoma (aUC): Final analysis of a phase Ib/II study
المؤلفون: O. Reig Torras, Tobias Arkenau, D. Castellano Gauna, Sang Joon Shin, Ulka N. Vaishampayan, Rafael Morales-Barrera, S.P. Dang, I. Lal, In Jae Chung, E. Chong, D-Y. Oh, George Cole, Ignacio Duran, P. Gajate Borau, C-H. Ju, Mark Tuthill
المصدر: Annals of Oncology. 31:S585-S586
بيانات النشر: Elsevier BV, 2020.
سنة النشر: 2020
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Hematology, chemistry.chemical_compound, Paclitaxel, chemistry, Internal medicine, Ibrutinib, medicine, In patient, business, Urothelial carcinoma
تدمد: 0923-7534
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::918ea05c21a86d126a37033462a52630
https://doi.org/10.1016/j.annonc.2020.08.826
حقوق: OPEN
رقم الأكسشن: edsair.doi...........918ea05c21a86d126a37033462a52630
قاعدة البيانات: OpenAIRE
الوصف
تدمد:09237534